Application 217221
- Type
- ANDA
- Sponsor
- DIFGEN PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LIDOCAINE | LIDOCAINE | PATCH;TOPICAL | 1.8% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A217221-001 | LIDOCAINE | LIDOCAINE | 1.8% | PATCH / TOPICAL | AB | 2025-03-25 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A217221-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A217221-001 | LIDOCAINE | 1.8% | PATCH / TOPICAL | AB | 2025-03-25 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A217221-001 | LIDOCAINE | 1.8% | PATCH / TOPICAL | AB | 2025-03-25 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A217221-001 | LIDOCAINE | 1.8% | PATCH / TOPICAL | AB | 2025-03-25 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217221-001 | LIDOCAINE | 1.8% | PATCH / TOPICAL | AB | 2025-03-25 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A217221-001 | LIDOCAINE | 1.8% | PATCH / TOPICAL | AB | 2025-03-25 | 6a471c1ec25d… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217221-001 | LIDOCAINE | 1.8% | PATCH / TOPICAL | AB | 2025-03-25 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A217221-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A217221-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A217221-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217221-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A217221-001 | AB | 1 | 6a471c1ec25d… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217221-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LIDOCAINE | LIDOCAINE | Alembic Pharmaceuticals Inc. | 11a8b27a-1e25-46e5-bc23-ae5c894b4da4 | 2023-10-30 | Warnings, Adverse reactions | LIDOCAINE LIDOCAINE |
| MAXIMUM STRENGTH HEMORRHOIDAL RELIEF | LIDOCAINE | CVS PHARMACY, INC | b61424bf-3b23-420b-a7bc-256ddb96aa22 | 2023-10-25 | Warnings | LIDOCAINE |
| MAXIMUM STRENGTH HEMORRHOIDAL RELIEF with Finger Cots | LIDOCAINE | CVS PHARMACY, INC | 82aa128a-44cd-4907-b0f7-8a31e086d3e6 | 2023-10-25 | Warnings | LIDOCAINE |
| Assured Bikini Smooth Cream | LIDOCAINE | Zhejiang Jingwei Pharmaceutical Co., Ltd. | fb9ddde3-3f40-467e-8aff-26570144f0fc | 2023-10-25 | Warnings | LIDOCAINE |
| Lidocaine 5% | LIDOCAINE | Apnar Pharma LP | ceedce20-5723-5a9a-e053-2a95a90a17a1 | 2023-10-21 | Warnings | LIDOCAINE |
| Microcaine Topical Analgesic | LIDOCAINE | Unit Dose, Ltd. | 5e8fa8b5-0524-4201-91e1-83e59a8f0415 | 2023-10-19 | Warnings | LIDOCAINE |
| Lidocaine | LIDOCAINE | Bryant Ranch Prepack | 6fe7721d-42b3-4284-936b-a448ca530c45 | 2023-09-14 | Warnings, Adverse reactions | Lidocaine LIDOCAINE |
| Lidocaine | LIDOCAINE | Septodont, Inc. | 82a4c16f-d47e-479f-8f85-7d1be6fc2318 | 2023-07-07 | Warnings, Adverse reactions | Lidocaine LIDOCAINE |
| Bactine Max Antibiotic and Lidocaine Max Pain Relief | LIDOCAINE | WellSpring Pharmaceutical Corporation | 71300df9-6113-4f25-93ca-28ad7e7f79de | 2023-06-08 | Warnings | LIDOCAINE |
| Lidocaine | LIDOCAINE | Proficient Rx LP | 2b9150ea-a876-4511-8d5b-aa72507ef863 | 2023-06-01 | Warnings, Adverse reactions | Lidocaine LIDOCAINE |
| Lidocaine | LIDOCAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 86083fea-c064-4ef7-e053-2a91aa0ac17c | 2023-05-16 | Warnings, Adverse reactions | Lidocaine |
| Lidocaine | LIDOCAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 86093c75-6dde-bb16-e053-2991aa0ab6ef | 2023-05-16 | Warnings, Adverse reactions | Lidocaine |
| Bactine Max Lidocaine Roll-on 2.5oz | LIDOCAINE | WellSpring Pharmaceutical Corporation | 09b32a98-9131-451e-87a6-81a1e4ed7ec5 | 2023-04-25 | Warnings | LIDOCAINE |
| lidocaine | LIDOCAINE | Asclemed USA, Inc. | 58c9afe4-dc36-4f71-8e76-8dff63dc35fb | 2023-03-27 | Warnings, Adverse reactions | lidocaine LIDOCAINE |
| Lidocaine | LIDOCAINE | Bryant Ranch Prepack | a134c265-4fb6-4c78-b9cc-fae8f1fff1cf | 2023-03-15 | Warnings, Adverse reactions | Lidocaine LIDOCAINE |
| Lidocaine | LIDOCAINE | Bryant Ranch Prepack | 68bc320f-2871-45b9-815e-bb26081e8249 | 2023-03-02 | Warnings, Adverse reactions | Lidocaine LIDOCAINE |
| Lidocaine | LIDOCAINE | Bryant Ranch Prepack | da9707e2-f830-45e2-a300-1f99cf3dd362 | 2023-02-20 | Warnings, Adverse reactions | Lidocaine LIDOCAINE |
| Lidocaine | LIDOCAINE | QUAGEN PHARMACEUTICALS LLC | f8789807-cc0c-485c-aa98-1bdc39337deb | 2023-02-15 | Warnings, Adverse reactions | Lidocaine LIDOCAINE |
| lidocaine | LIDOCAINE | Proficient Rx LP | 8a85ea77-91ad-4222-9bfe-2ffaf73182e8 | 2022-11-01 | Warnings, Adverse reactions | lidocaine LIDOCAINE |
| Lidocaine | LIDOCAINE | Asclemed USA, Inc. | 80dadfb5-cbe6-475f-9980-a1b255982753 | 2022-10-12 | Warnings, Adverse reactions | Lidocaine LIDOCAINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.